Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factor

J Natl Cancer Inst. 1991 Jan 16;83(2):129-31. doi: 10.1093/jnci/83.2.129.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Gastritis / chemically induced*
  • Gastrointestinal Hemorrhage / chemically induced*
  • Humans
  • Neoplasms / therapy*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / adverse effects*

Substances

  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha